Rezurock Tablet
Product Images NDC 79802-200

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Rezurock (NDC 79802-200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Kadmon Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 01)

Chemical structure of belumosudil, the active ingredient in Rezurock tablets (200 mg) by Kadmon Pharmaceuticals, LLC. The diagram depicts molecular bonds and groups characteristic of belumosudil sulfate.*

FDA Label Image

Principal Display Panel (Bottle Label)

Rezurock 200 mg (belumosudil) tablets packaging label. The label shows the product name and strength, dosage form as tablets, and quantity of 30 tablets. It indicates prescription use only and includes storage instructions. Distributed by Kadmon Pharmaceuticals, LLC, Warrendale, PA, and manufactured by UPM Pharmaceuticals, Bristol, TN. The label also notes the active ingredient is made in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.